|
1
|
Roberts LR: Sorafenib in liver cancer -
just the beginning. N Engl J Med. 359:420–422. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Llovet JM: Updated treatment approach to
hepatocellular carcinoma. J Gastroenterol. 40:225–235. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pang RW, Joh JW, Johnson PJ, Monden M,
Pawlik TM and Poon RT: Biology of hepatocellular carcinoma. Ann
Surg Oncol. 15:962–971. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang LY, Fang F, Ou DP, Wu W, Zeng ZJ and
Wu F: Solitary large hepatocellular carcinoma: a specific subtype
of hepatocellular carcinoma with good outcome after hepatic
resection. Ann Surg. 249:118–123. 2009. View Article : Google Scholar
|
|
5
|
Gao J, Chen H, Yu Y, et al: Inhibition of
hepatocellular carcinoma growth using immunoliposomes for
co-delivery of adriamycin and ribonucleotide reductase M2 siRNA.
Biomaterials. 34:10084–10098. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim NW, Piatyszek MA, Prowse KR, et al:
Specific association of human telomerase activity with immortal
cells and cancer. Science. 266:2011–2015. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Feng WDJ, Funk SS, Wang SL, et al: The RNA
component of human telomerase. Science. 269:1236–1241. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang PH, Zou L and Tu ZG: RNAi-hTERT
inhibition hepatocellular carcinoma cell proliferation via
decreasing telomerase activity. J Surg Res. 131:143–149. 2006.
View Article : Google Scholar
|
|
9
|
Sun PM, Wei LH, Luo MY, et al: The
telomerase activity and expression of hTERT gene can serve as
indicators in the anti-cancer treatment of human ovarian cancer.
Eur J Obstet Gynecol Reprod Biol. 130:249–257. 2007. View Article : Google Scholar
|
|
10
|
Toshikuni N, Nouso K, Higashi T, et al:
Expression of telomerase-associated protein 1 and telomerase
reverse transcriptase in hepatocellular carcinoma. Br J Cancer.
82:833–837. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Beattie TL, Zhou W, Robinson MO and
Harrington L: Reconstitution of human telomerase activity in vitro.
Curr Biol. 8:177–180. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Herbert B, Pitts AE, Baker SI, Hamilton
SE, Wright WE, Shay JW and Corey DR: Inhibition of human telomerase
in immortal human cells leads to progressive telomere shortening
and cell death. Proc Natl Acad Sci USA. 96:14276–14281. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Folini M and Zaffaroni N: Targeting
telomerase by antisense-based approaches: perspectives for new
anti-cancer therapies. Curr Pharm Des. 11:1105–1117. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Meyerson M, Counter CM, Eaton EN, et al:
hEST2, the putative human telomerase catalytic subunit gene, is
up-regulated in tumor cells and during immortalization. Cell.
90:785–795. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pannone G, De Maria S, Zamparese R, et al:
Prognostic value of human telomerase reverse transcriptase gene
expression in oral carcinogenesis. Int J Oncol. 30:1349–1357.
2007.PubMed/NCBI
|
|
16
|
Li W, Li L, Liu Z, et al: Expression of
the full-length telomerase reverse transcriptase (hTERT) transcript
in both malignant and normal gastric tissues. Cancer Lett.
260:28–36. 2008. View Article : Google Scholar
|
|
17
|
Nagao K, Tomimatsu M, Endo H, Hisatomi H
and Hikiji K: Telomerase reverse transcriptase mRNA expression and
telomerase activity in hepatocellular carcinoma. J Gastroenterol.
34:83–87. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gil Z, Rein A, Brader P, Li S, Shah JP,
Fong Y and Wong RJ: Nerve-sparing therapy with oncolytic herpes
virus for cancers with neural invasion. Clin Cancer Res.
13:6479–6485. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kelly K, Brader P, Rein A, Shah JP, Wong
RJ, Fong Y and Gil Z: Attenuated multimutated herpes simplex
virus-1 effectively treats prostate carcinomas with neural invasion
while preserving nerve function. FASEB J. 22:1839–1848. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tjuvajev JG, Joshi A, Callegari J, et al:
A general approach to the non-invasive imaging of transgenes using
cis-linked herpes simplex virus thymidine kinase. Neoplasia.
1:315–320. 1999. View Article : Google Scholar
|
|
21
|
Gambhir SS, Barrio JR, Phelps ME, et al:
Imaging adenoviral-directed reporter gene expression in living
animals with positron emission tomography. Proc Natl Acad Sci USA.
96:2333–2338. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Barzon L, Bonaguro R, Castagliuolo I, et
al: Gene therapy of thyroid cancer via retrovirally-driven combined
expression of human interleukin-2 and herpes simplex virus
thymidine kinase. Eur J Endocrinol. 148:73–80. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bertorelle R, Briarava M, Rampazzo E, et
al: Telomerase is an independent prognostic marker of overall
survival in patients with colorectal cancer. Br J Cancer.
108:278–284. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu H, Liu S, Wang H, et al: Genomic
amplification of the human telomerase gene (hTERC) associated with
human papillomavirus is related to the progression of uterine
cervical dysplasia to invasive cancer. Diagn Pathol. 7:1472012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sharma GG, Gupta A, Wang H, et al: hTERT
associates with human telomeres and enhances genomic stability and
DNA repair. Oncogene. 22:131–146. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kraemer K, Fuessel S, Kotzsch M, et al:
Chemosensitization of bladder cancer cell lines by human telomerase
reverse transcriptase antisense treatment. J Urol. 172:2023–2028.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hao ZM, Luo JY, Cheng J, et al: Intensive
inhibition of hTERT expression by a ribozyme induces rapid
apoptosis of cancer cells through a telomere length-independent
pathway. Cancer Biol Ther. 4:1098–1103. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sachsinger J, Gonzalez-Suarez E, Samper E,
Heicappell R, Müller M and Blasco MA: Telomerase inhibition in
RenCa, a murine tumor cell line with short telomeres, by
overexpression of a dominant negative mTERT mutant, reveals
fundamental differences in telomerase regulation between human and
murine cells. Cancer Res. 61:5580–5586. 2001.PubMed/NCBI
|
|
29
|
Shay JW, Zou Y, Hiyama E and Wright WE:
Telomerase and cancer. Hum Mol Genet. 10:677–685. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Massard C, Zermati Y, Pauleau AL,
Larochette N, et al: hTERT: a novel endogenous inhibitor of the
mitochondrial cell death pathway. Oncogene. 25:4505–4514. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kurvinen K, Syrjanen S and Johansson B:
Long-term suppression of telomerase expression in HeLa cell clones,
transfected with an expression vector carrying siRNA targeting
hTERT mRNA. Int J Oncol. 29:279–288. 2006.PubMed/NCBI
|
|
32
|
Gambhir SS, Herschman HR, Cherry SR, et
al: Imaging transgene expression with radionuclide imaging
technologies. Neoplasia. 2:118–138. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Northcott PA, Jones DT, Kool M, et al:
Medulloblastomics: the end of the beginning. Nat Rev Cancer.
12:818–834. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Stefani AL, Barzon L, Castagliuolo I, et
al: Systemic efficacy of combined suicide/cytokine gene therapy in
a murine model of hepatocellular carcinoma. J Hepatol. 42:728–735.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ahn YH, Yi H, Shin JY, et al: STAT3
silencing enhances the efficacy of the HSV. tk suicide gene in
gastrointestinal cancer therapy. Clin Exp Metastasis. 29:359–369.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Trinh QT, Austin EA, Murray DM, Knick VC
and Huber BE: Enzyme/prodrug gene therapy: comparison of cytosine
deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir
enzyme/prodrug systems in a human colorectal carcinoma cell line.
Cancer Res. 55:4808–4812. 1995.PubMed/NCBI
|
|
37
|
Bridgewater JA, Springer CJ, Knox RJ,
Minton NP, Michael NP and Collins MK: Expression of the bacterial
nitroreductase enzyme in mammalian cells renders them selectively
sensitive to killing by the prodrug CB1954. Eur J Cancer.
31:A2362–A2370. 1995. View Article : Google Scholar
|
|
38
|
Danks MK, Morton CL, Pawlik CA and Potter
PM: Overexpression of a rabbit liver carboxylesterase sensitizes
human tumor cells to CPT-11. Cancer Res. 58:20–22. 1998.PubMed/NCBI
|
|
39
|
Boerman OC, Oyen WJ and Corstens FH:
Progress in gene therapy: seeing is believing. J Nucl Med.
42:1235–1237. 2001.PubMed/NCBI
|
|
40
|
Huang TG, Savontaus MJ, Shinozaki K,
Sauter BV and Woo SL: Telomerase-dependent oncolytic adenovirus for
cancer treatment. Gene Ther. 10:1241–1247. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Nishihara E, Nagayama Y, Mawatari F, et
al: Retrovirus-mediated herpes simplex virus thymidine kinase gene
transduction renders human thyroid carcinoma cell lines sensitive
to ganciclovir and radiation in vitro and in vivo. Endocrinology.
138:4577–4583. 1997. View Article : Google Scholar : PubMed/NCBI
|
